Skip to main content

Advertisement

SpringerLink
Log in

Hypopituitarism in the elderly: a narrative review on clinical management of hypothalamic–pituitary–gonadal, hypothalamic–pituitary–thyroid and hypothalamic–pituitary–adrenal axes dysfunction

  • Short Review
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Hypopituitarism is an uncommon and under-investigated endocrine disorder in old age since signs and symptoms are unspecific and, at least in part, can be attributed to the physiological effects of aging and related co-morbidities. Clinical presentation is often insidious being characterized by non-specific manifestations, such as weight gain, fatigue, low muscle strength, bradipsychism, hypotension or intolerance to cold. In these circumstances, hypopituitarism is a rarely life-threatening condition, but evolution may be more dramatic as a result of pituitary apoplexy, or when a serious condition of adrenal insufficiency suddenly occurs. Clinical presentation depends on the effects that each pituitary deficit can cause, and on their mutual relationship, but also, inevitably, it depends on the severity and duration of the deficit itself, as well as on the general condition of the patient. Indeed, indications and methods of hormone replacement therapy must include the need to normalize the endocrine profile without contributing to the worsening of intercurrent diseases, such as those of glucose and bone metabolism, and the cardiovascular system, or to the increasing cancer risk. Hormonal requirements of elderly patients are reduced compared to young adults, but a prompt diagnosis and appropriate treatment of pituitary deficiencies are strongly recommended, also in this age range.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Schneider HJ, Aimaretti G, Kreitschmann-Andermahr I, Stalla GK, Ghigo E (2007) Hypopituitarism. Lancet 369:1461–1470

    Article  CAS  PubMed  Google Scholar 

  2. Higham CE, Johannsson G, Chalet SM (2016) Hypopituitarism. Lancet. doi:10.1016/S0140-6736(16)30053-8

    PubMed  Google Scholar 

  3. Ascoli P, Cavagnini F (2006) Hypopituitarism. Pituitary 9:335–342

    Article  CAS  PubMed  Google Scholar 

  4. Foppiani L, Ruelle A, Bandelloni R, Quilici P, Del Monte P (2008) Hypopituitarism in the elderly: multifaceted clinical and biochemical presentation. Curr Aging Sci 1:42–50

    Article  CAS  PubMed  Google Scholar 

  5. Antonopoulou M, Sharma R, Farag A, Banerji MA, Karam JG (2012) Hypopituitarism in the elderly. Maturitas 72:277–285

    Article  CAS  PubMed  Google Scholar 

  6. Lamberts SW, van den Beld AW, van der Lely AJ (1997) The endocrinology of aging. Science 278:419–424

    Article  CAS  PubMed  Google Scholar 

  7. Veldhuis JD (2013) Changes in pituitary function with ageing and implications for patient care. Nat Rev Endocrinol 9:205–215

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Blackman MR (1987) Pituitary hormones and aging. Endocrinol Metab Clin North Am 16:981–994

    CAS  PubMed  Google Scholar 

  9. Cavarzere P, Biban P, Gaudino R, Perlini S, Sartore L, Chini L, Silvagni D, Antoniazzi F (2014) Diagnostic pitfalls in the assessment of congenital hypopituitarism. J Endocrinol Invest 37:1201–1209

    Article  CAS  PubMed  Google Scholar 

  10. Lamberts SW, de Herder WW, van der Lely AJ (1998) Pituitary insufficiency. Lancet 352:127–134

    Article  CAS  PubMed  Google Scholar 

  11. Bates AS, Van’t Hoff W, Jones PJ, Clayton RN (1996) The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab 81:1169–1172

    CAS  PubMed  Google Scholar 

  12. Lewis AS, Courtney CH, Atkinson AB (2009) All patients with “idiopathic” hypopituitarism should be screened for hemochromatosis. Pituitary 12:273–275

    Article  PubMed  Google Scholar 

  13. Giustina A, Aimaretti G, Bondanelli M, Buzi F, Cannavò S, Cirillo S, Colao A, De Marinis L, Ferone D, Gasperi M, Grottoli S, Porcelli T, Ghigo E, degli Uberti E (2010) Primary empty sella: why and when to investigate hypothalamic–pituitary function. J Endocrinol Invest 33:343–346

    Article  CAS  PubMed  Google Scholar 

  14. Cannavò S, Curtò L, Venturino M, Squadrito S, Al moto B, Narbone MC, Rao R, Trimarchi F (2002) Abnormalities of hypothalamic–pituitary–thyroid axis in patients with primary empty sella. J Endocrinol Invest 25:236–239

    Article  PubMed  Google Scholar 

  15. Gasperi M, Aimaretti G, Cecconi E, Colao A, Di Somma C, Cannavò S, Baffoni C, Cosottini M, Curtò L, Trimarchi F, Lombardi G, Grasso L, Ghigo MartinoE (2002) Impairment of GH secretion in adults with primary empty sella. J Endocrinol Invest 25:329–333

    Article  CAS  PubMed  Google Scholar 

  16. Hannon MJ, Sherlock M, Thompson CJ (2011) Pituitary dysfunction following brain injury or subarachnoid haemorrhage in—“Endocrine management in the intensive care unit”. Best Pract Res Clin Endocrinol Metab 25:783–798

    Article  CAS  PubMed  Google Scholar 

  17. Schneider HJ, Kreitschmann-Andermahr I, Ghigo E, Stalla GK, Agha A (2007) Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage. JAMA 298:1429–1438

    Article  CAS  PubMed  Google Scholar 

  18. Tanriverdi F, Schneider HJ, Aimaretti G, Masel BE, Casanueva FF, Kelestimur F (2015) Pituitary dysfunction after traumatic brain injury: a clinical and pathophysiological approach. Endocr Rev 36:305–342

    Article  CAS  PubMed  Google Scholar 

  19. Aimaretti G, Ambrosio MR, Di Somma C, Fusco A, Cannavò S, Gaspari M, Scaroni C, De Marinis L, Benvenga S, degli Uberti EC, Lombardi G, Mantero F, Martino E, Giordano G, Ghigo E (2004) Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injury. Clin Endocrinol 61:320–326

    Article  CAS  Google Scholar 

  20. Benvenga S, Vigo T, Ruggeri RM, Lapa D, Almoto B, LoGiudice F, Longo M, Blandino A, Campennì A, Cannavò S, Trimarchi F (2004) Severe head trauma in patients with unexplained central hypothyroidism. Am J Med 116:767–771

    Article  PubMed  Google Scholar 

  21. Benvenga S, Campenní A, Ruggeri RM, Trimarchi F (2000) Clinical review 113: hypopituitarism secondary to head trauma. J Clin Endocrinol Metab 85:1353–1361

    Article  CAS  PubMed  Google Scholar 

  22. Zheng P, He B, Tong WS (2014) Decrease in pituitary apparent diffusion coefficient in normal appearing brain correlates with hypopituitarism following traumatic brain injury. J Endocrinol Invest 37:309–312

    Article  CAS  PubMed  Google Scholar 

  23. Kronvall E, Valdemarsson S, Säveland H, Nilsson OG (2015) High prevalence of pituitary dysfunction after aneurysmal subarachnoid hemorrhage: a long-term prospective study using dynamic endocrine testing. World Neurosurg 83:574–582

    Article  PubMed  Google Scholar 

  24. Bondanelli M, Ambrosio MR, Zatelli MC, Basaglia N, Degli Uberti EC (2008) Prevalence of hypopituitarism in patients with cerebrovascular disease. J Endocrinol Invest 31:16–20

    Article  CAS  PubMed  Google Scholar 

  25. Cannavò S, Marini F, Trimarchi F (2008) Patients with craniopharyngiomas: therapeutical difficulties with growth hormone. J Endocrinol Invest 31:56–60

    PubMed  Google Scholar 

  26. Castinetti F, Reynaud R, Quentien MH, Jullien N, Marquant E, Rochette C, Herman JP, Saveanu A, Barlier A, Enjalbert A, Brue T (2015) Combined pituitary hormone deficiency: current and future status. J Endocrinol Invest 38:1–12

    Article  CAS  PubMed  Google Scholar 

  27. Castinetti F, Reynaud R, Saveanu A, Barlier A, Brue T (2012) Genetic causes of combined pituitary hormone deficiency in humans. Ann Endocrinol 73:53–55

    Article  CAS  Google Scholar 

  28. McCabe MJ, Dattani MT (2014) Genetic aspects of hypothalamic and pituitary gland development. Handb Clin Neurol 124:3–15

    Article  PubMed  Google Scholar 

  29. Castinetti F, Saveanu A, Reynaud R, Quentien MH, Buffin A, Brauner R, Kaffel N, Albarel F, Guedj AM, El Kholy M, Amin M, Enjalbert A, Barlier A, Brue T (2008) A novel dysfunctional LHX4 mutation with high phenotypical variability in patients with hypopituitarism. J Clin Endocrinol Metab 93:2790–2799

    Article  CAS  PubMed  Google Scholar 

  30. Blethen SL (1996) Hypopituitarism. In: Lifshitz F (ed) Pediatric endocrinology. Marcel Dekker, New York, pp 19–23

    Google Scholar 

  31. Toogood AA, Stewart PM (2008) Hypopituitarism: clinical features, diagnosis and management. Endocrinol Metab Clin N Am 37:235–261

    Article  CAS  Google Scholar 

  32. Cikim A, Dikilitas M, Cikim K (2006) Hypopituitarism in older adults. The report of five cases with different presentations. Geriatrics 61:32–35

    PubMed  Google Scholar 

  33. Ferrucci L, Maggio M, Bandinelli S, Basaria S, Lauretani F, Ble A, Valenti G, Ershler WB, Guralnik JM, Longo DL (2006) Low testosterone levels and the risk of anemia in older men and women. Arch Intern Med 166:1380–1388

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Maggio M, Lauretani F, Ceda GP, Bandinelli S, Basaria S, Ble A, Egan J, Paolisso G, Najjar S, Jeffrey Metter E, Valenti G, Guralnik JM, Ferrucci L (2006) Association between hormones and metabolic syndrome in older Italian men. J Am Geriatr Soc 54:1832–1838

    Article  PubMed  PubMed Central  Google Scholar 

  35. Muller M, Grobbee DE, den Tonkelaar I, Lamberts SW, van der Schouw YT (2005) Endogenous sex hormones and metabolic syndrome in aging men. J Clin Endocrinol Metab 90:2618–2623

    Article  CAS  PubMed  Google Scholar 

  36. Stellato RK, Feldman HA, Hamdy O, Horton ES, McKinlay JB (2000) Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care 23:490–494

    Article  CAS  PubMed  Google Scholar 

  37. Orwoll E, Lambert LC, Marshall LM, Blank J, Barrett-Connor E, Cauley J, Ensrud K, Cummings SR (2006) Osteoporotic Fractures in Men Study Group. Endogenous testosterone levels, physical performance, and fall risk in older men. Arch Intern Med 166:2124–2131

    Article  PubMed  Google Scholar 

  38. Moffat SD, Zonderman AB, Metter EJ, Kawas C, Blackman MR, Harman SM, Resnick SM (2004) Free testosterone and risk for Alzheimer disease in older men. Neurology 62:188–193

    Article  CAS  PubMed  Google Scholar 

  39. Tran HA, Petrovsky N (2005) Hypothyroidism and hyponatraemia in the hospital setting. Pathology 37:179–181

    Article  CAS  PubMed  Google Scholar 

  40. Baajafer FS, Hammami MM, Mohamed GE (1999) Prevalence and severity of hyponatremia and hypercreatininemia in short-term uncomplicated hypothyroidism. J Endocrinol Invest 22:35–39

    Article  CAS  PubMed  Google Scholar 

  41. O’Brien T, Dinneen SF, O’Brien PC, Palumbo PJ (1993) Hyperlipidemia in patients with primary and secondary hypothyroidism. Mayo Clin Proc 68:860–866

    Article  PubMed  Google Scholar 

  42. Kaji H, Iida K, Takahashi Y, Okimura Y, Chihara K (2007) Hormone replacement therapy and vascular risk disorders in adult hypopituitarism. Endocr J 54:239–245

    Article  CAS  PubMed  Google Scholar 

  43. Mathew V, Misgar RA, Ghosh S, Mukhopadhyay P, Roychowdhury P, Pandit K, Mukhopadhyay S, Chowdhury S (2011) Myxedema coma: a new look into an old crisis. J Thyroid Res 2011:493462

    Article  PubMed  PubMed Central  Google Scholar 

  44. Diederich S, Franzen NF, Bähr V, Oelkers W (2003) Severe hyponatremia due to hypopituitarism with adrenal insufficiency: report on 28 cases. Eur J Endocrinol 148:609–617

    Article  CAS  PubMed  Google Scholar 

  45. Chanson P (2003) Severe hyponatriemia as a frequent revealing sign of hypopituitarism after 60 years of age. Eur J Endocrinol 149:177–178

    Article  CAS  PubMed  Google Scholar 

  46. Persani L (2012) Central hypothyroidism: pathogenic, diagnostic, and therapeutic challenges. J Clin Endocrinol Metab 97:3068–3078

    Article  CAS  PubMed  Google Scholar 

  47. Lee S, Farwell AP (2016) Euthyroid sick syndrome. Compr Physiol 6:1071–1080

    Article  PubMed  Google Scholar 

  48. Persani L, Ferretti E, Borgato S, Faglia G, Beck-Peccoz P (2000) Circulating thyrotropin bioactivity in sporadic central hypothyroidism. J Clin Endocrinol Metab 85:3631–3635

    CAS  PubMed  Google Scholar 

  49. Alexopoulou O, Beguin C, De Nayer P, Maiter D (2004) Clinical and hormonal characteristics of central hypothyroidism at diagnosis and during follow-up in adult patients. Eur J Endocrinol 150:1–8

    Article  CAS  PubMed  Google Scholar 

  50. van Aken MO, Lamberts SW (2005) Diagnosis and treatment of hypopituitarism: an update. Pituitary 8:183–191

    Article  PubMed  Google Scholar 

  51. Nieman LK (2003) Dynamic evaluation of adrenal hypofunction. J Endocrinol Invest 26:74–82

    CAS  PubMed  Google Scholar 

  52. Chitale A, Musonda P, McGregor AM, Dhatariya KK (2013) Determining the utility of the 60 min cortisol measurement in the short synacthen test. Clin Endocrinol 79:14–19

    Article  CAS  Google Scholar 

  53. Brooke AM, Kalingag LA, Miraki-Moud F, Camacho-Hübner C, Maher KT, Walker DM, Hinson JP, Monson JP (2006) Dehydroepiandrosterone improves psychological well-being in male and female hypopituitary patients on maintenance growth hormone replacement. J Clin Endocrinol Metab 91:3773–3779

    Article  CAS  PubMed  Google Scholar 

  54. Myers JB, Meacham RB (2003) Androgen replacement therapy in the aging male. Rev Urol 5:216–226

    PubMed  PubMed Central  Google Scholar 

  55. Borst SE, Mulligan T (2007) Testosterone replacement therapy for older men. Clin Interv Aging 2:561–566

    CAS  PubMed  PubMed Central  Google Scholar 

  56. Koulouri O, Auldin MA, Agarwal R, Kieffer V, Robertson C, Falconer Smith J, Levy MJ, Howlett TA (2011) Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine. Clin Endocrinol 74:744–749

    Article  CAS  Google Scholar 

  57. Feldt-Rasmussen U (2007) Treatment of hypothyroidism in elderly patients and in patients with cardiac disease. Thyroid 17:619–624

    Article  PubMed  Google Scholar 

  58. Ferretti E, Persani L, Jaffrain-Rea ML, Giambona S, Tamburrano G, Beck-Peccoz P (1999) Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism. J Clin Endocrinol Metab 84:924–929

    CAS  PubMed  Google Scholar 

  59. Kim S (2015) Diagnosis and treatment of hypopituitarism. Endocrinol Metab 30:443–455

    Article  Google Scholar 

  60. Forss M, Batcheller G, Skrtic S, Johannsson G (2012) Current practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency—a worldwide patient survey. BMC Endocr Disord 12:8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Bleicken B, Hahner S, Loeffler M, Ventz M, Decker O, Allolio B, Quinkler M (2009) Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency. Clin Endocrinol 72:297–304

    Article  Google Scholar 

  62. Bleicken B, Hahner S, Loeffler M, Ventz M, Allolio B, Quinkler M (2008) Impaired subjective health status in chronic adrenal insufficiency: impact of different glucocorticoid replacement regimens. Eur J Endocrinol 159:811–817

    Article  CAS  PubMed  Google Scholar 

  63. Lennernäs H, Skrtic S, Johannsson G (2008) Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors. Expert Opin Drug Metab Toxicol 4:749–758

    Article  PubMed  Google Scholar 

  64. Johannsson G, Bergthorsdottir R, Nilsson AG, Lennernas H, Hedner T, Skrtic S (2009) Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study. Eur J Endocrinol 161:119–130

    Article  CAS  PubMed  Google Scholar 

  65. Johannsson G, Burman P, Wiren L, Engstrom BE, Nilsson AG, Ottosson M, Jonsson B, Bengtsson BA, Karlsson FA (2002) Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial. J Clin Endocrinol Metab 87:2046–2052

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical and Experimental Medicine, Endocrinology Unit, University of Messina, AOU Policlinico “G. Martino” (Block H, Floor 4), Via Consolare Valeria, 1, 98125, Messina, Italy

    L. Curtò & F. Trimarchi

  2. Accademia Peloritana dei Pericolanti, University of Messina, Messina, Italy

    F. Trimarchi

Authors
  1. L. Curtò
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Trimarchi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L. Curtò.

Ethics declarations

Conflict of interest

The authors declare they have no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

No informed consent.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Curtò, L., Trimarchi, F. Hypopituitarism in the elderly: a narrative review on clinical management of hypothalamic–pituitary–gonadal, hypothalamic–pituitary–thyroid and hypothalamic–pituitary–adrenal axes dysfunction. J Endocrinol Invest 39, 1115–1124 (2016). https://doi.org/10.1007/s40618-016-0487-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-016-0487-8

Keywords

Search

Navigation